A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder

OBJECTIVES: To evaluate the efficacy and tolerability of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder (MDD). PATIENTS AND METHODS: This was a 10-week (8-week active treatment/2-week post-treatment) randomized, double-blind, pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Gang, McIntyre, Alexander, Earley, Willie R, Raines, Shane R, Eriksson, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916085/
https://www.ncbi.nlm.nih.gov/pubmed/24511235
http://dx.doi.org/10.2147/NDT.S50248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916085/
https://www.ncbi.nlm.nih.gov/pubmed/24511235
http://dx.doi.org/10.2147/NDT.S50248

Ejemplares similares